Published in Int J Radiat Oncol Biol Phys on October 01, 1998
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.71
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology (2008) 1.32
Radiation therapy after radical prostatectomy: why patience is a virtue! The case for salvage radiation therapy. Rev Urol (2002) 1.07
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy. J Cancer Res Clin Oncol (2009) 0.90
Salvage radiotherapy following radical prostatectomy. World J Urol (2003) 0.78
Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy. Cancer Med (2014) 0.77
Therapy of recurrent disease after radical prostatectomy in 2007. World J Urol (2007) 0.76
Adjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis. PLoS One (2014) 0.75
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial. Biomed Res Int (2014) 0.75
The role of postoperative radiotherapy in prostate cancer patients. Contemp Oncol (Pozn) (2013) 0.75
Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology (1992) 2.51
Combined pre- and postoperative adjuvant radiation therapy for bladder cancer--a ten year experience. Int J Radiat Oncol Biol Phys (1992) 2.24
The surgical implications of herniation of the urinary bladder. Arch Surg (1985) 2.23
Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer (1998) 1.89
Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res (1992) 1.75
The effect of digital rectal examination on prostate-specific antigen levels. JAMA (1992) 1.66
High-frequency (10-18 kHz) hearing thresholds: reliability, and effects of age and occupational noise exposure. Occup Med (Lond) (2001) 1.62
Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest (2001) 1.61
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesth Analg (1993) 1.58
Entonox® inhalation to reduce pain in common diagnostic and therapeutic outpatient urological procedures: a review of the evidence. Ann R Coll Surg Engl (2012) 1.58
Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology (2001) 1.51
Evidence of RPGRIP1 gene mutations associated with recessive cone-rod dystrophy. J Med Genet (2003) 1.44
Management of radial keratotomy overcorrections by corneal sutures. J Cataract Refract Surg (1993) 1.39
The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol (1999) 1.28
Occupational noise exposure and hearing loss of workers in two plants in eastern Saudi Arabia. Ann Occup Hyg (2001) 1.26
The primary antibacterial defense mechanism of the bladder. Invest Urol (1975) 1.24
A novel locus for Leber congenital amaurosis (LCA4) with anterior keratoconus mapping to chromosome 17p13. Invest Ophthalmol Vis Sci (2000) 1.23
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys (2001) 1.22
A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys (1999) 1.20
Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol (1997) 1.20
Role of surface mucin in primary antibacterial defense of bladder. Urology (1977) 1.19
Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys (1998) 1.18
Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.15
Biopsychosocial aspects of prostate cancer. Psychosomatics (2000) 1.14
Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am (1999) 1.13
Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients. J Clin Oncol (1997) 1.13
External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae. Int J Radiat Oncol Biol Phys (1997) 1.12
Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma. Br J Cancer (1985) 1.11
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Transm Dis (1999) 1.11
Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol (1987) 1.11
Targeting cell cycle and hormone receptor pathways in cancer. Oncogene (2013) 1.10
Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys (1995) 1.09
Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin). Infect Immun (1979) 1.09
Bull's-eyes and halos: useful MR discriminators of osseous metastases. Radiology (1993) 1.08
Identification of novel mutations in the SEMA4A gene associated with retinal degenerative diseases. J Med Genet (2005) 1.08
Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control? Int J Radiat Oncol Biol Phys (1995) 1.08
In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches. J Pharmacol Exp Ther (1997) 1.07
Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology (1998) 1.06
MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer. Oncogene (2008) 1.06
The effect of the availability of latrines on soil-transmitted nematode infections in the plantation sector in Sri Lanka. Am J Trop Med Hyg (1994) 1.05
Retroperitoneal and pelvic extraperitoneal laparoscopy: an international perspective. Urology (1998) 1.05
Familial pheochromocytoma associated with cerebellar hemangioblastoma. A case history and review of the literature. JAMA (1969) 1.04
Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect. Invest Urol (1978) 1.04
Prostate cancer: contrast-enhanced us for detection. Radiology (2001) 1.04
Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology (1994) 1.02
The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol (2000) 1.02
Endoscopic ureteroureterostomy for obliterated ureteral segments. J Urol (1996) 1.02
Colorectal carcinoma in patients younger than 40 years of age. Montpellier Cancer Institute experience with 78 patients. Cancer (1988) 1.02
Novel association of RP1 gene mutations with autosomal recessive retinitis pigmentosa. J Med Genet (2005) 1.02
Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol (1997) 1.01
Mesh erosion into the bladder: a late complication of incisional hernia repair. A case report and review of the literature. Hernia (2003) 1.01
Vital signs for children at triage: a multicentre validation of the revised South African Triage Scale (SATS) for children. S Afr Med J (2013) 1.00
Metanephric adenoma: histology, immunophenotype, cytogenetics, ultrastructure. Mod Pathol (1996) 1.00
Inhibition of DNA synthesis in Ehrlich ascites cells by actinomycin D. II. The presynthetic block in the cell cycle. Proc Natl Acad Sci U S A (1965) 1.00
Refinement of the locus for autosomal recessive Retinitis pigmentosa (RP25) linked to chromosome 6q in a family of Pakistani origin. Am J Hum Genet (1999) 0.99
Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins. Cancer (1993) 0.98
Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations. Blood (1986) 0.98
Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol (1989) 0.98
Aggressive angiomyxoma of the perineum in a man. J Urol (1997) 0.97
Bladder surface mucin. Its antibacterial effect against various bacterial species. Am J Pathol (1978) 0.97
Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (1999) 0.97
Novel locus for autosomal recessive cone-rod dystrophy CORD8 mapping to chromosome 1q12-Q24. Invest Ophthalmol Vis Sci (2000) 0.95
Effect of ammonium on bacterial adherence to bladder transitional epithelium. J Urol (1984) 0.95
Imaging prostate cancer: current and future applications. Oncology (Williston Park) (2001) 0.95
Molecular genetics of bladder cancer: targets for diagnosis and therapy. J Exp Clin Cancer Res (2006) 0.95
Renal cell carcinoma in the presence of adult polycystic kidney disease. Urology (1994) 0.94
Role of urothelial surface mucoprotein in intrinsic bladder defense. Urology (1977) 0.94
Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology (1997) 0.93
Trauma management in a war zone: the Lebanese war experience. J Trauma (1991) 0.93
Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys (1997) 0.93
The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys (1999) 0.93
The prevalence and control of soil-transmitted nematode infections among children and women in the plantations in Sri Lanka. Ceylon Med J (1996) 0.93
Respiration-induced motion of the kidneys in whole abdominal radiotherapy: implications for treatment planning and late toxicity. Radiother Oncol (1997) 0.93
A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn. J Perinatol (2011) 0.93
Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology (2001) 0.92
Phenotype of autosomal recessive congenital microphthalmia mapping to chromosome 14q32. Br J Ophthalmol (1999) 0.91
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder. Am J Pathol (2000) 0.91
Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells. Cancer Res (1992) 0.91
Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate (1992) 0.91
Initial experience with contrast-enhanced sonography of the prostate. AJR Am J Roentgenol (2000) 0.91
Ocular effects of the venom from the spitting cobra (Naja nigricollis). J Toxicol Clin Toxicol (1986) 0.90
Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature. Obstet Gynecol Surv (1983) 0.90
Locus for autosomal recessive nonsyndromic persistent hyperplastic primary vitreous. Invest Ophthalmol Vis Sci (2001) 0.90
Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. J Urol (2001) 0.90
A study of hospital urinary tract infections. J Urol (1973) 0.90
A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers. J Urol (1986) 0.90